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Hydrogen sulfide (H 2 S) is a colorless gas with a characteristic rotten-egg odor found in various natural and industrial sources. 3 In mammalian tissues, H 2 S is generated through the degradation of L-cysteine mainly by 2 enzymes, cystathionine ␤-synthase (CBS) and cystathionine ␥-lyase (CGL). 4 Both CBS and CGL are expressed at high levels in liver, kidney, and pancreas, presumably for cysteine synthesis. CGL is also expressed in brain, heart, and smooth muscle. 5, 6 Although deficiency of CBS causes hyperhomocysteinemia, an established risk factor for cardiovascular disorders including sudden cardiac death, CGL deficiency causes cystathioninuria, an apparently benign condition albeit with an inconsistent and variable disease association. 7 H 2 S exerts a host of biological effects on various targets, resulting in responses that range from cytotoxic to cytoprotective effects. 5 Although breathing high concentrations of H 2 S is toxic, 5 breathing low concentrations of H 2 S reversibly reduces metabolism in rodents and improves survival after hemorrhagic shock in rats. 8 -10 Although administration of NaHS has been shown to worsen cerebral ischemia 11 and lipopolysaccharide-induced systemic inflammation, 12 recent studies showed that administration of NaHS or Na 2 S can attenuate ischemia/reperfusion (IR) injury in heart, [13] [14] [15] liver, 16 and kidney. 17 The protective effects of H 2 S appear to be mediated via antiapoptotic and/or anti-inflammatory effects. However, the impact of Na 2 S on the outcome of CA/CPR, which is complicated by whole body IR injury and systemic inflammation, remains to be elucidated. In the present study, we report that administration of Na 2 S at the time of CPR markedly improves myocardial and neurological function and survival after CA/CPR in mice.
Methods

Mice
After approval by the Massachusetts General Hospital Subcommittee on Research Animal Care, we studied 2-to 3-month-old age-and weight-matched male C57BL/6J wild-type and nitric oxide synthase 3 (NOS3)-deficient mice on a C57BL/6J background (NOS3 Ϫ/Ϫ ). We also studied 2-to 3-month-old male mice with cardiomyocytespecific overexpression of CGL (CS-CGLtg) 13 and their wild-type littermates (FVBN/J).
Material
Sodium sulfide (Na 2 S; IK-1001) was a generous gift from Ikaria Inc (Seattle, Wash). Na 2 S was produced by using H 2 S gas (Matheson, Newark, Calif) as a starting material and was formulated to pH neutrality and iso-osmolarity. Na 2 S was diluted in normal (0.9%) saline to the desired concentration immediately before administration.
Animal Preparation
Mice were anesthetized with 100 g/g ketamine and 0.25 g/g fentanyl delivered by intraperitoneal injection and mechanically ventilated (FIO 2 ϭ0.21; Minivent, Harvard Apparatus). Arterial blood pressure was measured via a left femoral arterial line. A saline-filled microcatheter (PE-10, Becton Dickinson) was inserted into the left femoral vein for drug and fluid administration. Blood pressure and needle-probe ECG monitoring data were recorded and analyzed with the use of a PC-based data acquisition system.
Murine CPR Model
CA was induced by administration of 0.08 mg/g potassium chloride through the femoral catheter and was confirmed by loss of arterial pressure and asystolic rhythm on ECG. After 8 minutes of CA, chest compressions were delivered with a finger at a rate of 340 to 360 beats per minute with resumption of mechanical ventilation (FIO 2 ϭ1.0). Chest compressions were adjusted to provide a uniform rate seen on femoral artery pressure monitoring and a target femoral diastolic pressure of Ͼ20 mm Hg. Epinephrine was infused at 0.3 g/min starting 30 seconds before CPR and continued until heart rate became Ͼ300 bpm. Core body temperature was maintained at 37°C by a warming lamp. Return of spontaneous circulation (ROSC) was defined as the return of sinus rhythm with a mean arterial pressure Ͼ40 mm Hg lasting at least 1 minute. Mice were weaned from mechanical ventilation at 1 hour after and extubated at 2 hours after CPR. In a subgroup of mice, at 24 hours after CPR, cardiac function was examined with a conductance pressure-volume catheter (SPR-839, Millar Instruments Inc) under anesthesia. Mice subjected to sham surgery that were not subjected to CA were used as controls.
Study drug (Na 2 S) or vehicle was injected via the femoral venous line 1 minute before CPR. On the basis of pilot studies, we administered 0.55 mg/kg (7.0 mol/kg) Na 2 S. Effects of delayed administration of Na 2 S at 10 minutes after the start of CPR (post-CPR Na 2 S) were examined in a subgroup of mice.
Assessment of Neurological Function
Neurological function was assessed at 24 hours after CA/CPR or sham surgery with the use of a previously reported neurological function scoring system with minor modifications (see Methods in the online-only Data Supplement). 18, 19 
Effects of Na 2 S on Myocardial Function in Isolated-Perfused Mouse Heart
Mice were heparinized and anesthetized with the use of pentobarbital (60 mg/kg IP). The heart was removed quickly and mounted on a 20-gauge cannula in ice-cold perfusion buffer (a modified Krebs-Henseleit buffer, containing [in mmol/L] 118.5 NaCl, 24.9 NaHCO 3 , 11.2 glucose, 4 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 2 sodium pyruvate, and 2.5 CaCl 2 ). Retrograde perfusion was started with the use of perfusion buffer continuously gassed with 95% O 2 /5% CO 2 at 37°C. A constant hydrostatic coronary pressure of 65 mm Hg was maintained throughout the experiment. The tip of an SPR-671 transducer (Millar Instruments, Houston, Tex) was placed in a saline-filled polyvinyl chloride balloon that was inserted into the left ventricle (LV). The balloon was inflated to obtain a diastolic pressure of 5 to 10 mm Hg, and LV pressure was monitored via the Millar transducer and continuously recorded. LV developed pressure, rate-pressure product, maximum and minimum rate of LV pressure change (dP/dt max and dP/dt min ), and the time constant of isovolumic LV relaxation () were calculated. Hearts were electrically paced at 7 Hz with the use of a Grass S88 stimulator (Grass Technologies, West Warwick, RI). Coronary flow rate was measured with an N1 in-line flowprobe and a T106 flowmeter (Transonic Systems, Ithaca, NY). After a 30-minute stabilization period, hearts were subjected to 20 minutes of ischemia followed by 60 minutes of reperfusion. Na 2 S (10 mol/L) or vehicle was administered into the perfusate starting immediately or 40 seconds after the start of reperfusion and continued for 5 minutes. Myocardial function was measured for the first 60 minutes after reperfusion.
Measurement of Serum Nitrite/Nitrate
Concentrations of nitrite and nitrate were measured in serum samples obtained at 15 minutes after CA/CPR or sham surgery with a Nitrate/Nitrite Fluorometric Assay Kit (Cayman Chemical, Ann Arbor, Mich) according to the manufacturer's instructions.
Mitochondrial Permeability Transition
Mouse heart mitochondria were isolated 15 minutes after CA/CPR or sham operation by differential centrifugation with the use of the MITO-ISO1 kit (Sigma-Aldrich, St Louis, Mo) following the manufacturer's instructions. Mitochondrial permeability transition was measured by monitoring the decrease in absorbance at 540 nm associated with mitochondrial swelling, as described previously. 20 Briefly, mitochondrial suspensions were diluted to a final concentration of 0.5 mg/mL in a buffer containing (in mmol/L) 200 mannitol, 70 sucrose, 10 HEPES, and 5 succinate (pH 7.4). After 2 minutes of stabilization, 400 mol/L CaCl 2 was added to induce mitochondrial permeability transition. The decrease in absorbance was monitored for 1000 seconds at room temperature with a spectrophotometer. The maximal rate of the absorbance decrease was obtained by linear regression over a 3-minute period.
Measurements of Peroxide Levels in Serum
Concentrations of hydrogen peroxide were measured in serum samples obtained at 5 minutes after CA/CPR or sham surgery with a QuantiChrom Peroxide Assay Kit (BioAssay Systems, Hayward, Calif) according to the manufacturer's instructions.
Detailed description of reagents and protocol for immunoblots and histological studies are provided in Methods in the online-only Data Supplement.
Statistical Analysis
All data are expressed as meanϮSEM. Normally distributed data were analyzed with the use of unpaired t test, 2-way repeatedmeasures ANOVA, or 1-way ANOVA with a Holm-Sidak or Bonferroni post hoc test. Neurological function scores of CS-CGLtg versus FVBN/J wild-type mice were compared by Mann-Whitney rank sum test because the values are not normally distributed. Difference in survival rate was analyzed by Gehan-Breslow test. Sigmastat 3.01a (Systat Software Inc, San Jose, Calif) and GraphPad Prism 5.0 (GraphPad Software Inc, La Jolla, Calif) were used for statistical analyses.
Results
Na 2 S Improves Survival Rate After CA and CPR
The rate of ROSC was Ͼ95% in mice treated with either vehicle or Na 2 S. There was no difference between treatment groups in the CPR time to ROSC or the total epinephrine dose ( Table I in the online-only Data Supplement). Although only 10 of 26 mice treated with vehicle survived 24 hours after CPR, all 15 mice treated with Na 2 S 1 minute before CPR survived 24 hours after CA and CPR (Pϭ0.0001; Figure 1 ). In contrast, delayed administration of Na 2 S at 10 minutes after CPR did not improve the survival rate at 24 hours after CPR (5 of 11 survived; Pϭ0.9 versus vehicle). Although formal long-term survival analysis was not done in the present study, in our pilot studies, Ͼ90% of mice treated with Na 2 S recovered completely by 72 hours after CPR and lived indefinitely. On the other hand, Ͻ20% of vehicle-treated mice survived 72 hours after CPR. Because delayed administration of Na 2 S did not improve survival compared with vehicle, neurological and myocardial function and tissue injury were compared between groups of mice that received vehicle or Na 2 S 1 minute before CPR.
Na 2 S Improved Neurological Function 24 Hours After CA and CPR
Although neurological function was depressed in surviving mice 24 hours after CA/CPR, it was better in Na 2 S-treated mice than in vehicle-treated mice (PϽ0.0001; Figure 2A ).
Na 2 S Prevents Apoptosis in Brain After CA and CPR
Immunoblot analysis revealed that caspase 3 was activated at 15 minutes after CA/CPR in cerebral cortex of vehicle-treated mice ( Figure 2B ). The caspase 3 activation was markedly attenuated by Na 2 S. Histological studies revealed that the number of neurons containing cleaved caspase 3 in the CA1 region of the hippocampus was markedly increased at 24 hours after CA/CPR ( Figure 2C and 2D) . Similarly, the number of dead neurons identified by morphological criteria 21 in the CA1 region was markedly increased at 72 hours after CA/CPR (Figure 2E and 2F). Administration of Na 2 S 1 minute before CPR decreased the numbers of cleaved caspase 3-positive or dead neurons in the hippocampus. Because phosphorylation of GSK-3␤ has been suggested to inhibit apoptosis, we examined phosphorylation status of GSK-3␤ in the brain cortex extracts. The neuroprotective effects of Na 2 S were associated with enhanced GSK-3␤ phosphorylation at Ser 9 ( Figure 2G ). These results suggest that administration of Na 2 S 1 minute before CPR prevents apoptosis in the brain.
Na 2 S Prevents Myocardial Dysfunction After CA and CPR
There was no difference in heart rate and mean arterial pressure between mice treated with vehicle or Na 2 S at ROSC or 60 minutes after CPR (Supplemental Table I in the online-only Data Supplement). Twenty-four hours after CA/ CPR, heart rate, LV end-systolic pressure, dP/dt max , end-systolic elastance, and preload-recruitable stroke work were depressed in vehicle-treated mice compared with sham but not in Na 2 S-treated mice (Table) . Myocardial mechanical efficiency (estimated by the ratio of end-systolic elastance to arterial elastance) was impaired (decreased ratio) in vehicletreated mice but not in Na 2 S-treated mice (Table) . These results show that administration of Na 2 S at the time of CPR prevents post-CA myocardial dysfunction 24 hours after CA/CPR.
Na 2 S Improves Myocardial Function After In Vitro IR
To examine the impact of Na 2 S on myocardial function after global IR, we studied the effects of Na 2 S in isolated-perfused mouse hearts. Myocardial function was depressed after 20 minutes of ischemia in vehicle-treated hearts. Administration of Na 2 S (10 mol/L) starting at the time of reperfusion after 20 minutes of ischemia markedly improved the recovery of myocardial function ( Figure 3A through 3F ). Recovery of both systolic (dP/dt max , LV developed pressure, and ratepressure product) and diastolic (dP/dt min and ) myocardial function was markedly augmented by Na 2 S compared with vehicle. Na 2 S also improved the recovery of coronary flow. Of note, delaying the start of administration of Na 2 S by 40 seconds after the start of reperfusion abolished the protective effects of Na 2 S on myocardial function after IR ( Figure I in the online-only Data Supplement). These results further support the concept that Na 2 S can preserve cardiac function after global myocardial IR when it is administered at the time of reperfusion.
Na 2 S Attenuates Oxidative Stress and Protects Mitochondria in the Heart After CA and CPR
CA accelerated the rate of Ca 2ϩ -induced mitochondrial swelling, a measure of mitochondrial permeability transition pore opening, compared with the mitochondria of sham-operated mice. Na 2 S prevented the acceleration of Ca 2ϩ -induced mitochondrial swelling in cardiac mitochondria after CA/CPR ( Figure 4A and 4B) . Na 2 S also prevented CA-induced increments in hydrogen peroxide levels in serum 5 minutes after CPR ( Figure 4C ). These results suggest that Na 2 S attenuates oxidative stress early after CA/CPR and protects cardiac mitochondria.
Cardiomyocyte-Specific Overexpression of CGL Improves Outcomes After CA and CPR
To examine the impact of endogenously produced H 2 S in the heart on the recovery from CA/CPR, we studied CS-CGLtg mice, which have been characterized extensively and display increased H 2 S production in the heart. 13 Compared with their wild-type littermates, CS-CGLtg mice had a markedly shorter CPR time to ROSC (516Ϯ62 versus 331Ϯ24 seconds; Pϭ0.016), required a smaller dose of epinephrine to achieve ROSC (1.5Ϯ0.2 versus 0.9Ϯ0.1 g; Pϭ0.015), and had a higher mean arterial pressure at 60 minutes after CPR (28Ϯ2 versus 35Ϯ3 mm Hg; Pϭ0.046). Additionally, CS-CGLtg mice had markedly improved neurological function (8Ϯ1 [medianϭ7] versus 5Ϯ1 [medianϭ4.5]; Pϭ0.048 by Mann-Whitney rank sum test) and survival rate (8 of 11 versus 4 of 13; Pϭ0.03; Figure 5 ) 24 hours after CA/CPR. These results suggest that augmented cardiac H 2 S levels facilitated recovery after CA/CPR.
Na 2 S Increases Phosphorylation of Akt and AMP-Activated Protein Kinase ␣ After CA and CPR
Because Akt-and AMP-activated protein kinase (AMPK)dependent signal contributes to cell survival in variety of pathological conditions, 22, 23 we sought to investigate the role of Akt and AMPK in the protective effects of Na 2 S. CA and CPR increased Akt phosphorylation in LV compared with sham-operated mice ( Figure 6A ). Administration of Na 2 S 1 minute before CPR increased Akt phosphorylation at Ser 473 compared with vehicle both in the LV and brain after CA/CPR ( Figure 6A and 6B ). CA and CPR decreased phosphorylation of NOS3 at Ser 1179 in the LV and brain ( Figure 6C and 6D ). Administration of Na 2 S prevented the dephosphorylation of NOS3 at Ser 1179 both in LV and brain after CA/CPR. Similarly, CA/CPR-induced dephosphorylation of AMPK␣ at Thr 172 was prevented by Na 2 S in the brain ( Figure 6E ). Of note, delayed administration of Na 2 S at 10 minutes after CPR (post-CPR Na 2 S) failed to increase the phosphorylation of Akt, NOS3, and AMPK␣ compared with vehicle after CA/CPR. These observations suggest that protective effects of Na 2 S on organ function are associated with activation of Akt-and/or AMPK␣-dependent prosurvival signals.
Na 2 S Prevents Reduction of Nitrite/Nitrate Levels After CA and CPR
To examine whether the protective effects of Na 2 S were associated with augmented NO production, we measured serum nitrite and nitrate levels at 15 minutes after CA/CPR. Compared with sham-operated mice (4.7Ϯ0.8 mol/L), nitrite/nitrate levels were decreased in vehicle-treated mice (3.2Ϯ0.8 mol/L; PϽ0.01 versus sham) but not in Na 2 Streated mice (4.3Ϯ0.2 mol/L; Pϭ0.35 versus sham, PϽ0.05 versus vehicle-treated mice) 15 minutes after CA/CPR.
Na 2 S Does Not Improve Outcome of CA and CPR in NOS3-Deficient Mice
To elucidate the role of NOS3/NO in the protective effects of Na 2 S, we examined whether Na 2 S improves outcomes of CA/CPR in NOS3 Ϫ/Ϫ mice. Only 1 of 7 NOS3 Ϫ/Ϫ mice survived 24 hours after CA/CPR, and administration of Na 2 S 1 minute before CPR did not improve the survival rate in NOS3 Ϫ/Ϫ mice (1 of 7 survived; Figure 6F ). These results suggest that the protective effects of Na 2 S on the outcome of CA/CPR require NOS3.
Discussion
The present study revealed that administration of Na 2 S at the time of CPR markedly improves myocardial and neurological function and survival after CA/CPR in mice. The neuroprotective effects of Na 2 S were associated with attenuated CA/CPR-induced caspase 3 activation in the brain. Global myocardial IR in isolated-perfused heart model confirmed the protective effects of Na 2 S. Administration of Na 2 S also prevented systemic oxidative stress and acceleration of mitochondrial permeability transition in the heart. Enhanced endogenous H 2 S production by cardiomyocyte-specific overexpression of CGL improved outcomes after CA/CPR. The salutary impact of Na 2 S treatment on the outcome of CA/CPR was associated with preserved serum nitrite and nitrate levels and enhanced phosphorylation of Akt and NOS3 in the brain and heart and AMPK␣ and GSK-3␤ in the brain. Finally, NOS3 deficiency abrogated the protective effects of Na 2 S on the outcome of CA/CPR. Taken together, these observations suggest that H 2 S confers organ protection and improves survival after CA/CPR at least in part via an NOS3-dependent mechanism.
The majority of research on CA over the past half century has focused on improving the rate of ROSC, and significant progress has been made. However, many patients succumb to the post-CA syndrome after successful resuscitation. The present study was designed to investigate whether H 2 S could improve the outcome after "successful" resuscitation. Although there was no difference in the rate of ROSC or CPR time to ROSC, mice that received Na 2 S immediately before CPR showed a markedly higher survival rate at 24 hours than did mice that received vehicle before CPR or Na 2 S 10 minutes after CPR. These observations suggest that administration of Na 2 S at the time of CPR improved outcomes at 24 hours after CA by preventing the development of post-CA organ injury and dysfunction after ROSC. The present results suggest that Na 2 S can protect against the development of post-CA neurological dysfunction and injury when administered at the time of CPR (Figure 2A ). CA and CPR activated caspase 3 and induced cell death in the brain of vehicle-treated mice. In contrast, the improved neurological function at 24 hours after CPR in mice treated with Na 2 S was associated with marked attenuation of caspase 3 activation and cell death in the brain after CPR. Previously, Qu and colleagues 11 showed that administration of NaHS increased brain infarct volume after permanent middle cerebral artery occlusion. Differences in the models and the higher dose of NaHS (180 mol/kg of NaHS, equivalent to Ϸ90 mol/kg of Na 2 S 24 ) used in the Qu study compared with the present study (7 mol/kg of Na 2 S) may explain the conflicting results of these studies. 16 Proapoptotic effects of relatively high concentrations of H 2 S have also been reported in pancreas. 25 Nonetheless, our results suggest that physiological level of H 2 S can have important protective effects on ischemic brain injury.
To examine the molecular mechanisms responsible for the antiapoptotic effects of Na 2 S, we tested whether Na 2 S promotes Akt-or AMPK-dependent prosurvival signals in the brain. We found that Na 2 S increased phosphorylation of Akt and GSK-3␤ in the brain cortex. Akt-dependent phosphorylation of GSK-3␤ inhibits GSK-3␤ activity and thereby decreases apoptosis. 26, 27 Similarly, administration of Na 2 S 1 minute before CPR prevented the CA/CPR-induced dephosphorylation of AMPK␣ and NOS3. It has been reported that activation of cGMP-dependent protein kinase may confer cardioprotection via GSK-3␤. 27 It is conceivable that Aktand/or AMPK␣-dependent NOS3 activation activates the cGMP-dependent protein kinase-dependent neuroprotective mechanism via GSK-3␤ phosphorylation in our model. Similar to neurological function, myocardial function at 24 hours after CA/CPR was also improved by administration of Na 2 S (Table) . These results are reinforced by our findings that administration of Na 2 S starting immediately after reperfusion, but not when administered 40 seconds after reperfusion, markedly improved myocardial function in the isolated-perfused mouse heart subjected to global IR. These results are consistent with a previous report that NaHS was cardioprotective in isolated rat hearts. 15 The relatively narrow temporal window of opportunity for Na 2 S to improve the outcome of CA/CPR is consistent with previous studies of ischemic postconditioning. For example, Cohen and colleagues 28 recently reported that delay of the onset of postconditioning by only 1 minute aborts protection in rabbit hearts.
Mitochondrial permeability transition is a central mechanism of IR-induced death. 20 Na 2 S prevented CA/CPR-induced acceleration of Ca 2ϩ -induced mitochondrial swelling, a measure of mitochondrial permeability transition, in LV mitochondria. The beneficial effect of Na 2 S was associated with attenuated oxidative stress indicated by decreased serum hydrogen peroxide levels ( Figure  4C ). Oxidative stress has been shown to trigger mitochondrial permeability transition. 29 These observations suggest that the cardioprotective effects of Na 2 S may be mediated by inhibition of mitochondrial permeability transition. Figure 6 . Phosphorylated protein expression in brain cortex and LV 15 minutes after sham operation or CA/CPR in mice treated with vehicle or Na 2 S 1 minute before CPR (Veh and Na 2 S, respectively) or Na 2 S administered at 10 minutes after CPR (post-CPR Na 2 S). Relative phospho-Akt Ser 473 levels were quantified by dividing the phospho-Akt Ser 473 immunoreactivity by total Akt immunoreactivity and normalized to values of sham-operated mice in the heart (A) and brain (B). Relative phospho-NOS3 Ser 1179 levels were quantified by dividing the phospho-NOS3 Ser 1179 immunoreactivity by total NOS3 immunoreactivity and normalized to values of sham-operated mice in the heart (C) and brain (D). Relative phospho-AMPK␣ Thr 172 levels were quantified by dividing the phospho-AMPK␣ Thr 172 immunoreactivity by total AMPK␣ immunoreactivity and normalized to values of sham-operated mice in the brain (E). Two representative blots are shown of 6 to 8 blots in each group for all proteins. Loading controls are shown to demonstrate equal sample loading. *PϽ0.05 vs sham; #PϽ0.05 vs vehicle; †PϽ0.05 vs Na 2 S. F, Survival during the first 24 hours after CA and CPR in NOS3 Ϫ/Ϫ mice treated with vehicle (NOS3 Ϫ/Ϫ ϩVehicle; nϭ7) and NOS3 Ϫ/Ϫ mice treated with Na 2 S (NOS3 Ϫ/Ϫ ϩNa 2 S; nϭ7).
